<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">APY</journal-id>
<journal-id journal-id-type="hwp">spapy</journal-id>
<journal-title>Australasian Psychiatry</journal-title>
<issn pub-type="ppub">1039-8562</issn>
<issn pub-type="epub">1440-1665</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1039856212458979</article-id>
<article-id pub-id-type="publisher-id">10.1177_1039856212458979</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Treatments</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Use of ultra-brief pulse electroconvulsive therapy to treat severe postnatal mood disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Levy</surname><given-names>Yael</given-names></name>
<aff id="aff1-1039856212458979">Consultant Psychiatrist, St John of God Hospital, Burwood, NSW, Australia</aff>
</contrib>
<contrib contrib-type="author">
<name><surname>Austin</surname><given-names>Marie-Paule</given-names></name>
<aff id="aff2-1039856212458979">Chair of Perinatal &amp; Women’s Mental Health Unit, University of New South Wales, and St John of God Health Care, Sydney, NSW, Australia</aff>
</contrib>
<contrib contrib-type="author">
<name><surname>Halliday</surname><given-names>Graeme</given-names></name>
<aff id="aff3-1039856212458979">Senior Staff Specialist, Concord Centre for Mental Health, Concord, NSW, Australia</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="corresp1-1039856212458979">Dr Yael Levy, St John of God Hospital, 13 Grantham Street, Burwood, NSW 2134, Australia Email: <email>dryaellevy@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>10</month>
<year>2012</year>
</pub-date>
<volume>20</volume>
<issue>5</issue>
<fpage>429</fpage>
<lpage>432</lpage>
<permissions>
<copyright-statement>© The Royal Australian and New Zealand College of Psychiatrists 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">The Royal Australian and New Zealand College of Psychiatrists</copyright-holder>
</permissions>
<abstract>
<sec id="section1-1039856212458979">
<title>Objective:</title>
<p>To describe the use of ultra-brief electroconvulsive therapy (ECT) in three postnatal women with severe, treatment resistant depression. The indications and evidence for the use of ECT in the treatment of postnatal depression are discussed.</p>
</sec>
<sec id="section2-1039856212458979">
<title>Method:</title>
<p>We present a case series and review relevant literature.</p>
</sec>
<sec id="section3-1039856212458979">
<title>Results:</title>
<p>Three patients with severe episodes of depression postnatally, not responding to medication, presented to a private mother-baby inpatient unit. All three patients had significant suicidal ideation and two underwent involuntary treatment in public hospitals during the course of their presenting illnesses. They were treated with right unilateral ultra-brief ECT and a range of medications. All women began to respond within 3–6 treatments and no significant cognitive side effects were observed.</p>
</sec>
<sec id="section4-1039856212458979">
<title>Conclusions:</title>
<p>Our findings suggest that right unilateral ultra-brief ECT is a useful treatment modality for severe and treatment resistant depression in the postnatal period. ECT is a useful option in women who have experienced significant medication side effects, or for those whose severity of illness necessitates rapid symptom resolution. Ultra-brief ECT caused minimal clinically observable side effects, which may assist mothers to resume care of their infants more rapidly.</p>
</sec>
</abstract>
<kwd-group>
<kwd>depression</kwd>
<kwd>electroconvulsive therapy</kwd>
<kwd>postnatal mood disorder</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Although the use of electroconvulsive therapy (ECT) for treatment of severe depression and other mental disorders has been well established,<sup><xref ref-type="bibr" rid="bibr1-1039856212458979">1</xref>,<xref ref-type="bibr" rid="bibr2-1039856212458979">2</xref></sup> it still creates controversy.<sup><xref ref-type="bibr" rid="bibr3-1039856212458979">3</xref>,<xref ref-type="bibr" rid="bibr4-1039856212458979">4</xref></sup> It is therefore important for clinicians to be aware of the evidence for the use of ECT in special and vulnerable populations.<sup><xref ref-type="bibr" rid="bibr5-1039856212458979">5</xref></sup></p>
<p>For severely depressed postpartum women, ECT has been advocated as an effective treatment option. It is usually used in mothers who are suicidal or infanticidal, or who have a drug-resistant severe depression. It may also be advantageous in breastfeeding mothers who do not want to expose their infants to medication. However, apart from a small study conducted in 1961 that was not blinded and did not use standardised assessments of outcome,<sup><xref ref-type="bibr" rid="bibr6-1039856212458979">6</xref></sup> there is no experimental research examining the efficacy of ECT in a postnatal population.<sup><xref ref-type="bibr" rid="bibr5-1039856212458979">5</xref></sup> There is, however, a widespread belief that puerperal disorders respond particularly well to ECT.<sup><xref ref-type="bibr" rid="bibr7-1039856212458979">7</xref></sup></p>
<p>There is currently no information on the use of the newer ultra-brief form of ECT in postnatal populations. Ultra-brief pulse ECT uses a narrower pulse-width of 0.3 milliseconds, which is postulated to stimulate a smaller band of tissue, minimising stimulation of adjacent, non-targeted brain areas, and thus reducing associated side-effects.<sup><xref ref-type="bibr" rid="bibr8-1039856212458979">8</xref></sup> In view of the lack of data on ultra-brief ECT in postnatal patients, we report this case series of three depressed women.</p>
<sec id="section5-1039856212458979" sec-type="methods">
<title>Method</title>
<p>Three consecutive patients admitted to a mother-baby ward in a private hospital setting who were diagnosed with severe postnatal depression, and treated with right unilateral ultra-brief ECT were selected for inclusion. All patients underwent physical examination, baseline blood tests and electrocardiogram prior to commencement of ECT. ECT was performed three times per week and each patient was treated until they achieved remission of symptoms.</p>
<p>Treatments were carried out in a dedicated ECT suite in a private psychiatric hospital, using a MECTA spectrum 5000M machine, upgraded to dispense an ultra-brief pulse width. Seizure threshold was only titrated at the first session. At the time of this case series, there was no protocol standardising the dose above seizure threshold being given. Subsequent dosages were determined by the treating clinician. Adequate seizures were defined as greater than or equal to 15 seconds in duration with adequate post-ictal suppression.</p>
<p>Women were administered the Edinburgh Postnatal Depression Scale (EPDS)<sup><xref ref-type="bibr" rid="bibr9-1039856212458979">9</xref></sup> and the Depression, Anxiety and Stress Scale (DASS-21)<sup><xref ref-type="bibr" rid="bibr10-1039856212458979">10</xref></sup> before and after their course of ECT. Side effects (including effects on memory) were assessed at twice weekly clinical interview. No formal testing of cognition was performed.</p>
</sec>
<sec id="section6-1039856212458979" sec-type="results">
<title>Results</title>
<p>Patients 1 (aged 40 years) and 2 (37years) had melancholic depression and patient 3 (34 years) was psychotically depressed following an episode of manic psychosis. All three women had severe melancholic depressive symptoms and were significantly suicidal. Patient 3 also had psychotic features. Patient 2 and patient 3 required involuntary treatment in public hospitals during the course of their illnesses.</p>
<p>Patient 2 had significant psychiatric co-morbidities, including post-traumatic stress disorder with onset occurring following a motor vehicle accident. She also had an associated panic disorder with agoraphobia. Her past history included recurrent episodes of treatment resistant major depression dating back to the age of 18 years. Patient 1 had a post-partum psychosis following the birth of her first child. Patient 3 had no past psychiatric history. Both patient 2 and patient 3 had significant family histories. All three patients had received medication before commencing treatment with ECT. <xref ref-type="table" rid="table1-1039856212458979">Table 1</xref> summarises the medications they took prior to and during their course of ECT.</p>
<table-wrap id="table1-1039856212458979" position="float">
<label>Table 1.</label>
<caption>
<p>Medication prior to and during electroconvulsive therapy (ECT)</p>
</caption>
<graphic alternate-form-of="table1-1039856212458979" xlink:href="10.1177_1039856212458979-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th/>
<th align="left">Patient 1</th>
<th align="left">Patient 2</th>
<th align="left">Patient 3</th>
</tr>
</thead>
<tbody>
<tr>
<td><bold>Medications prior to ECT</bold></td>
<td>Desvenlafaxine 50 mg<break/><italic>3 days of treatment; discontinued - side effects</italic><break/>Sertraline 25 mg<break/><italic>7 days of treatment; discontinued - side effects</italic><break/>Amisupiride 200 mg<break/><italic>Commenced immediately postnatally (prophylaxis)</italic><break/>Seroquel 100 mg bd</td>
<td>Lovan 60 mg<break/><italic>6 months of treatment; discontinued – ineffective</italic><break/>Tegretol 200 mg bd<break/><italic>18 months of treatment; discontinued – pre-ECT, also ineffective</italic></td>
<td>Olanzapine 20 mg<break/><italic>10 days of treatment; discontinued - side effects</italic><break/>Haloperidol 10 mg<break/><italic>2.5 weeks of treatment; discontinued - severe extrapyramidal side effects</italic><break/>Sodium valproate 1000 mg<break/><italic>Discontinued - switched to lithium (childbearing age)</italic><break/>Quetiapine 400 mg<break/>Risperidone 4 mg</td>
</tr>
<tr>
<td><bold>Concurrent medications during ECT</bold></td>
<td>Amisulpiride 200 mg bd<break/>Prothiaden 150 mg<break/>Commenced mid-way through ECT.</td>
<td>Olanzapine 20 mg<break/><italic>Short term use during ECT to treat agitation</italic><break/>Tranylcypramine 20 mg bd<break/><italic>Commenced late in second week of ECT</italic></td>
<td>Risperidone 2 mg Quilonum<break/><italic>Commenced on 450 mg towards end of course; increased to 900 mg</italic><break/>Quetiapine 100 mg</td>
</tr>
</tbody>
</table></table-wrap>
<p><xref ref-type="table" rid="table2-1039856212458979">Table 2</xref> summarises some parameters of the ECT. Each patient began to show a clinical improvement in symptoms by the third to sixth treatment. The total number of treatments in each course were 9, 10 and 20. None of the patients were switched to standard right unilateral or bilateral ECT. None of the patients reported any anterograde or retrograde amnesia at clinical interview.</p>
<table-wrap id="table2-1039856212458979" position="float">
<label>Table 2.</label>
<caption>
<p>Parameters of electroconvulsive therapy (ECT)</p>
</caption>
<graphic alternate-form-of="table2-1039856212458979" xlink:href="10.1177_1039856212458979-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th/>
<th align="left">Patient 1</th>
<th align="left">Patient 2</th>
<th align="left">Patient 3</th>
</tr>
</thead>
<tbody>
<tr>
<td><bold>Electrode placement</bold></td>
<td>RUL</td>
<td>RUL</td>
<td>RUL</td>
</tr>
<tr>
<td><bold>Total treatments</bold></td>
<td>10</td>
<td>20</td>
<td>9</td>
</tr>
<tr>
<td><bold>Clinical improvement</bold></td>
<td>6<sup>th</sup> treatment</td>
<td>6<sup>th</sup> treatment</td>
<td>3<sup>rd</sup> treatment</td>
</tr>
<tr>
<td><bold>Seizure threshold (mc)</bold></td>
<td>No seizure during titration</td>
<td>138</td>
<td>115</td>
</tr>
<tr>
<td><bold>Initial dose (mc)</bold></td>
<td>207</td>
<td>138</td>
<td>115</td>
</tr>
<tr>
<td><bold>Final dose (mc)</bold></td>
<td>426</td>
<td>195</td>
<td>134</td>
</tr>
<tr>
<td><bold>Mean dose (mc)</bold></td>
<td>283.3</td>
<td>179.7</td>
<td>125</td>
</tr>
<tr>
<td><bold>Total dose (mc)</bold></td>
<td>2833</td>
<td>3594</td>
<td>1129</td>
</tr>
<tr>
<td><bold>Cognitive side effects</bold></td>
<td>Nil</td>
<td>Nil</td>
<td>Nil</td>
</tr>
<tr>
<td><bold>Anaesthetic drugs</bold></td>
<td>Propofol<break/>Remifentanil<break/>Suxamethonium</td>
<td>Propofol<break/>Suxamethonium</td>
<td>Propofol<break/>Suxamethonium</td>
</tr>
<tr>
<td><bold>Mean seizure duration (sec)</bold></td>
<td>20</td>
<td>34</td>
<td>33</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1039856212458979">
<p>RUL: right unilateral</p>
</fn>
</table-wrap-foot></table-wrap>
<p>EPDS and DASS-21 scores are displayed in <xref ref-type="table" rid="table3-1039856212458979">Table 3</xref>. Patient 3 was too unwell to complete these tools on admission and these were not collected on discharge. Both patient 1 and patient 2 experienced marked improvement by the time of discharge.</p>
<table-wrap id="table3-1039856212458979" position="float">
<label>Table 3.</label>
<caption>
<p>Questionnaire scores</p>
</caption>
<graphic alternate-form-of="table3-1039856212458979" xlink:href="10.1177_1039856212458979-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th/>
<th align="left">Patient 1</th>
<th align="left">Patient 2</th>
<th align="left">Patient 3</th>
</tr>
</thead>
<tbody>
<tr>
<td><bold>DASS (A)</bold></td>
<td>D: 36 A: 26 S: 26</td>
<td>D: 32 A: 22 S: 20</td>
<td>-</td>
</tr>
<tr>
<td><bold>DASS (D)</bold></td>
<td>D: 0 A: 0 S: 0</td>
<td>D: 0 A: 10 S: 2</td>
<td>-</td>
</tr>
<tr>
<td><bold>EPDS (A)</bold></td>
<td>22</td>
<td>21</td>
<td>-</td>
</tr>
<tr>
<td><bold>EPDS (D)</bold></td>
<td>2</td>
<td>4</td>
<td>-</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-1039856212458979">
<p>DASS: Depression Anxiety Stress Scales; EPDS: Edinburgh Postnatal Depression Scale; (A): Admission; (D): Discharge.</p>
</fn>
</table-wrap-foot></table-wrap>
</sec>
<sec id="section7-1039856212458979" sec-type="discussion">
<title>Discussion</title>
<p>Apart from potentially serious consequences for the mother herself, severe postnatal depression can have a deleterious impact in numerous other ways. It may jeopardise maternal-infant interactions<sup><xref ref-type="bibr" rid="bibr11-1039856212458979">11</xref></sup> and result in negative perceptions of infant behaviour.<sup><xref ref-type="bibr" rid="bibr12-1039856212458979">12</xref></sup> This may lead to attachment insecurity,<sup><xref ref-type="bibr" rid="bibr13-1039856212458979">13</xref><xref ref-type="bibr" rid="bibr14-1039856212458979"/>–<xref ref-type="bibr" rid="bibr15-1039856212458979">15</xref></sup> emotional developmental delay<sup><xref ref-type="bibr" rid="bibr13-1039856212458979">13</xref>,<xref ref-type="bibr" rid="bibr15-1039856212458979">15</xref></sup> and social difficulties.<sup><xref ref-type="bibr" rid="bibr16-1039856212458979">16</xref>,<xref ref-type="bibr" rid="bibr17-1039856212458979">17</xref></sup> Cognitive skills,<sup><xref ref-type="bibr" rid="bibr18-1039856212458979">18</xref></sup> expressive language development<sup><xref ref-type="bibr" rid="bibr19-1039856212458979">19</xref></sup> and attention<sup><xref ref-type="bibr" rid="bibr20-1039856212458979">20</xref></sup> in infants may also be negatively influenced by postnatal depression, and it has also been reported that children of depressed mothers are two to five times more likely to develop long-term behavioural problems,<sup><xref ref-type="bibr" rid="bibr21-1039856212458979">21</xref>,<xref ref-type="bibr" rid="bibr22-1039856212458979">22</xref></sup> Child neglect and abuse,<sup><xref ref-type="bibr" rid="bibr19-1039856212458979">19</xref></sup> marital stress resulting in separation or divorce,<sup><xref ref-type="bibr" rid="bibr23-1039856212458979">23</xref>,<xref ref-type="bibr" rid="bibr24-1039856212458979">24</xref></sup> and maternal and infant mortality are other potential outcomes. In order to alleviate suffering in mothers and prevent these corollaries of postnatal mood disorder, it is essential to define and validate the treatment options available to postpartum women.</p>
<p>ECT may be a good option for those who cannot wait for the delayed onset of action of drugs, those concerned about medication side effects and those with gross impairments in self-care, cognition, and judgment that threaten safety and well-being.<sup><xref ref-type="bibr" rid="bibr25-1039856212458979">25</xref></sup> In a postpartum population, there is an even greater imperative for a speedy recovery because of the impact of the mother’s illness on her baby. Some mothers may also choose ECT because of concerns about medication in the breast-milk and the potential harm to the infant.</p>
<p>However, use of ECT can be limited by adverse cognitive effects. These include a variable period of disorientation after each treatment, anterograde amnesia and retrograde amnesia. In postpartum women, these side effects may limit a mother’s ability to rapidly resume caring for her infant. The potential loss of memories of one’s infant in their first weeks or months is also a matter that may legitimately concern patients.</p>
<p>Manipulation of the pulse width of the electrical stimulus is a prominent technique currently under examination<sup><xref ref-type="bibr" rid="bibr26-1039856212458979">26</xref></sup> that seeks to minimise adverse effects of ECT. Analysis of cognitive outcomes in patients treated with ultrabrief pulse width has demonstrated significantly less impairment of anterograde and retrograde memory compared to patients receiving standard pulsewidth stimulation, for both RUL and bilateral ECT.</p>
<p>Thus far, clinical research involving ultrabrief pulsewidth in ECT has been limited. The main evidence comes from two double-blind, randomized controlled trials and an effectiveness trial.<sup><xref ref-type="bibr" rid="bibr26-1039856212458979">26</xref><xref ref-type="bibr" rid="bibr27-1039856212458979"/>–<xref ref-type="bibr" rid="bibr28-1039856212458979">28</xref></sup> There is no experimental research examining the efficacy of ultra-brief ECT in a postnatal population.</p>
<p>Although there is a commonly held belief that puerperal disorders are more sensitive than non-puerperal disorders to ECT, or more sensitive to ECT than other treatments,<sup><xref ref-type="bibr" rid="bibr7-1039856212458979">7</xref></sup> there are no published data clearly confirming this notion. Reed and colleagues<sup><xref ref-type="bibr" rid="bibr7-1039856212458979">7</xref></sup> found that the clinical improvement following ECT was greater in postpartum psychosis compared to non-postpartum psychosis. However, there were a number of methodological difficulties with the study, including reliance on retrospective examination of case notes and use of crude outcome measures.</p>
</sec>
<sec id="section8-1039856212458979">
<title>Limitations</title>
<p>The research presented describes a series of only three cases and the results may not be generalisable. Objective symptom measures were not obtained in one patient; however, ongoing review by a senior clinician suggested that this patient was in remission. Formal cognitive testing was not performed. Hence, any conclusions about tolerability need further verification. Patient 1 and patient 2 were commenced on new antidepressants during the course of ECT. These drugs may have had a synergistic impact on the response to ECT but it is unlikely that they were solely responsible for recovery.</p>
</sec>
<sec id="section9-1039856212458979" sec-type="conclusions">
<title>Conclusion</title>
<p>Right unilateral ultra-brief ECT is an effective treatment in the postnatal period for mothers suffering from severe mood disorder. The outcomes of this case series support the widely held, but poorly validated, view that this population responds particularly well to ECT. Ultra-brief ECT may have the added benefit of minimal cognitive side-effects, allowing mothers to more rapidly resume caring for their baby. More research is required to validate this approach.</p>
</sec>
</body>
<back>
<ack><p>The authors are grateful for the infrastructure support provided by St John of God Health Care and Hospital, Burwood, Sydney.</p></ack>
<fn-group>
<fn fn-type="conflict">
<label>Disclosure</label>
<p>The authors report no conflict of interest and are solely responsible for the content and writing of the paper.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1039856212458979">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Potter</surname><given-names>WZ</given-names></name>
<name><surname>Rudorfer</surname><given-names>MW</given-names></name>
</person-group>. <article-title>Electroconvulsive therapy—a modern medical procedure</article-title>. <source>N Engl J Med</source> <year>1993</year>; <volume>328</volume>: <fpage>882</fpage>–<lpage>883</lpage>.</citation>
</ref>
<ref id="bibr2-1039856212458979">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fink</surname><given-names>M</given-names></name>
</person-group>. <article-title>Indications for use of ECT</article-title>. <source>Psychopharmacol Bull</source> <year>1994</year>; <volume>30</volume>: <fpage>269</fpage>–<lpage>275</lpage>.</citation>
</ref>
<ref id="bibr3-1039856212458979">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cloud</surname><given-names>J</given-names></name>
</person-group>. <article-title>New sparks over electroshock</article-title>. <source>Time Magazine</source>, <month>February</month> <year>2001</year>, pp.<fpage>46</fpage>–<lpage>48</lpage>.</citation>
</ref>
<ref id="bibr4-1039856212458979">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Smith</surname><given-names>D</given-names></name>
</person-group>. <article-title>Shock and disbelief</article-title>. <source>Atlantic Monthly</source>, <month>February</month> <year>2001</year>, pp.<fpage>79</fpage>–<lpage>90</lpage>.</citation>
</ref>
<ref id="bibr5-1039856212458979">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rabheru</surname><given-names>K</given-names></name>
</person-group>. <article-title>The use of electroconvulsive therapy in special patient populations</article-title>. <source>Can J Psychiatry</source>. <year>2001</year>; <volume>46</volume>: <fpage>710</fpage>–<lpage>719</lpage>.</citation>
</ref>
<ref id="bibr6-1039856212458979">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Baker</surname><given-names>AA</given-names></name>
<name><surname>Morison</surname><given-names>M</given-names></name>
<name><surname>Game</surname><given-names>JA</given-names></name>
<etal/></person-group>. <article-title>Admitting schizophrenic mothers with their babies</article-title>. <source>Lancet</source> <year>1961</year>; <volume>2</volume>: <fpage>237</fpage>–<lpage>239</lpage>.</citation>
</ref>
<ref id="bibr7-1039856212458979">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Reed</surname><given-names>P</given-names></name>
<name><surname>Sermin</surname><given-names>N</given-names></name>
<name><surname>Appleby</surname><given-names>L</given-names></name>
<etal/></person-group>. <article-title>A comparison of clinical response to electroconvulsive therapy in puerperal and non-puerperal psychosis</article-title>. <source>J Affect Disord</source> <year>1999</year>; <volume>54</volume>: <fpage>255</fpage>–<lpage>260</lpage>.</citation>
</ref>
<ref id="bibr8-1039856212458979">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sackheim</surname><given-names>H</given-names></name>
</person-group>. <article-title>Convulsant and anticonvulsant properties of electroconvulsive therapy: towards a focal form of brain stimulation</article-title>. <source>Clin Neuroscience Res</source> <year>2004</year>; <volume>4</volume>: <fpage>39</fpage>–<lpage>57</lpage>.</citation>
</ref>
<ref id="bibr9-1039856212458979">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cox</surname><given-names>JL</given-names></name>
<name><surname>Holden</surname><given-names>JM</given-names></name>
<name><surname>Sagovsky</surname><given-names>R</given-names></name>
</person-group>. <article-title>Detection of postnatal depression: development of the 10-item Edinburgh Depression Scale</article-title>. <source>Br J Psychiatry</source> <year>1987</year>; <volume>150</volume>: <fpage>782</fpage>–<lpage>786</lpage>.</citation>
</ref>
<ref id="bibr10-1039856212458979">
<label>10.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Lovibond</surname><given-names>SH</given-names></name>
<name><surname>Lovibond</surname><given-names>PF</given-names></name>
</person-group>. (<year>1993</year>) <source>Manual for the depression, anxiety and stress scales</source>. <edition>2nd ed.</edition> Psychology Foundation Monograph. <publisher-loc>Sydney, Australia</publisher-loc>: <publisher-name>University of New South Wales</publisher-name>.</citation>
</ref>
<ref id="bibr11-1039856212458979">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Murray</surname><given-names>L</given-names></name>
<name><surname>Fiori-Cowley</surname><given-names>A</given-names></name>
<name><surname>Hooper</surname><given-names>R</given-names></name>
<etal/></person-group>. <article-title>The impact of postnatal depression and associated adversity on early mother-infant interactions and later infant outcome</article-title>. <source>Child Dev</source> <year>1996</year>; <volume>67</volume>: <fpage>2512</fpage>–<lpage>2526</lpage>.</citation>
</ref>
<ref id="bibr12-1039856212458979">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mayberry</surname><given-names>LJ</given-names></name>
<name><surname>Affonso</surname><given-names>DD</given-names></name>
</person-group>. <article-title>Infant temperament and postpartum depression: a review</article-title>. <source>Health Care Women Int</source> <year>1993</year>;<volume>14</volume>: <fpage>201</fpage>–<lpage>211</lpage>.</citation>
</ref>
<ref id="bibr13-1039856212458979">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hipwell</surname><given-names>AE</given-names></name>
<name><surname>Goossens</surname><given-names>FA</given-names></name>
<name><surname>Melhuish</surname><given-names>EC</given-names></name>
<etal/></person-group>. <article-title>Severe maternal psychopathology and infant-mother attachment</article-title>. <source>Dev Psychopathol</source> <year>2000</year>; <volume>12</volume>:<fpage>157</fpage>–<lpage>175</lpage>.</citation>
</ref>
<ref id="bibr14-1039856212458979">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Murray</surname><given-names>L</given-names></name>
</person-group>. <article-title>The impact of postnatal depression on infant development</article-title>. <source>J Child Psychol Psychiatry</source> <year>1992</year>; <volume>33</volume>: <fpage>543</fpage>–<lpage>561</lpage>.</citation>
</ref>
<ref id="bibr15-1039856212458979">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cogill</surname><given-names>SR</given-names></name>
<name><surname>Caplan</surname><given-names>HL</given-names></name>
<name><surname>Alexandra</surname><given-names>H</given-names></name>
<etal/></person-group>. <article-title>Impact of maternal postnatal depression on cognitive development of young children</article-title>. <source>Br Med J</source> (Clin Res Ed) <year>1986</year>; <volume>292</volume>: <fpage>1165</fpage>–<lpage>1167</lpage>.</citation>
</ref>
<ref id="bibr16-1039856212458979">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cummings</surname><given-names>EM</given-names></name>
<name><surname>Davies</surname><given-names>PT</given-names></name>
</person-group>. <article-title>Maternal depression and child development</article-title>. <source>J Child Psychol Psychiatry</source> <year>1994</year>; <volume>35</volume>: <fpage>73</fpage>–<lpage>112</lpage>.</citation>
</ref>
<ref id="bibr17-1039856212458979">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Murray</surname><given-names>L</given-names></name>
<name><surname>Sinclair</surname><given-names>D</given-names></name>
<name><surname>Cooper</surname><given-names>P</given-names></name>
<etal/></person-group>. <article-title>The socioemotional development of 5-year-old children of postnatally depressed mothers</article-title>. <source>J Child Psychol Psychiatry</source> <year>1999</year>; <volume>40</volume>: <fpage>1259</fpage>–<lpage>1271</lpage>.</citation>
</ref>
<ref id="bibr18-1039856212458979">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Whiffen</surname><given-names>VE</given-names></name>
<name><surname>Gotlib</surname><given-names>IH</given-names></name>
</person-group>. <article-title>Infants of postpartum depressed mothers: temperament and cognitive status</article-title>. <source>J Abnorm Psychol</source> <year>1989</year>; <volume>98</volume>: <fpage>274</fpage>–<lpage>279</lpage>.</citation>
</ref>
<ref id="bibr19-1039856212458979">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cox</surname><given-names>AD</given-names></name>
<name><surname>Puckering</surname><given-names>C</given-names></name>
<name><surname>Pound</surname><given-names>A</given-names></name>
<etal/></person-group>. <article-title>The impact of maternal depression in young children</article-title>. <source>J Child Psychol Psychiatry</source> <year>1987</year>; <volume>28</volume>: <fpage>917</fpage>–<lpage>928</lpage>.</citation>
</ref>
<ref id="bibr20-1039856212458979">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Breznitz</surname><given-names>Z</given-names></name>
<name><surname>Friedman</surname><given-names>SL</given-names></name>
</person-group>. <article-title>Toddlers’ concentration: does maternal depression make a difference?</article-title> <source>J Child Psychol Psychiatry</source> <year>1988</year>; <volume>29</volume>: <fpage>267</fpage>–<lpage>279</lpage>.</citation>
</ref>
<ref id="bibr21-1039856212458979">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beck</surname><given-names>CT</given-names></name>
</person-group>. <article-title>Maternal depression and child behaviour problems: a meta-analysis</article-title>. <source>J Adv Nurs</source> <year>1999</year>; <volume>29</volume>: <fpage>623</fpage>–<lpage>629</lpage>.</citation>
</ref>
<ref id="bibr22-1039856212458979">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Orvaschel</surname><given-names>H</given-names></name>
<name><surname>Walsh-Allis</surname><given-names>G</given-names></name>
<name><surname>Ye</surname><given-names>WJ</given-names></name>
</person-group>. <article-title>Psychopathology in children of parents with recurrent depression</article-title>. <source>J Abnorm Child Psychol</source> <year>1988</year>; <volume>16</volume>: <fpage>17</fpage>–<lpage>28</lpage>.</citation>
</ref>
<ref id="bibr23-1039856212458979">
<label>23.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Boyce</surname><given-names>P</given-names></name>
</person-group>. <article-title>Personality dysfunction, marital problems and postnatal depression</article-title>. In: <person-group person-group-type="editor">
<name><surname>Cox</surname><given-names>J</given-names></name>
<name><surname>Holden</surname><given-names>J</given-names></name>
</person-group> (eds) <source>Perinatal psychiatry: use and misuse of the Edinburgh Postnatal Depression Scale</source>. <publisher-loc>London, England</publisher-loc>: <publisher-name>Gaskell</publisher-name>; <year>1994</year>: pp. <fpage>82</fpage>–<lpage>102</lpage>.</citation>
</ref>
<ref id="bibr24-1039856212458979">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Holden</surname><given-names>JM</given-names></name>
</person-group>. <article-title>Postnatal depression: its nature, effects, and identification using the Edinburgh Postnatal Depression scale</article-title>. <source>Birth</source> <year>1991</year>; <volume>18</volume>: <fpage>211</fpage>–<lpage>221</lpage>.</citation>
</ref>
<ref id="bibr25-1039856212458979">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sit</surname><given-names>D</given-names></name>
<name><surname>Rothschild</surname><given-names>A</given-names></name>
<name><surname>Wisner</surname><given-names>KL</given-names></name>
</person-group>. <article-title>A review of postpartum psychosis</article-title>. <source>J Women’s Health</source> <year>2006</year>; <volume>15</volume>: <fpage>352</fpage>–<lpage>368</lpage>.</citation>
</ref>
<ref id="bibr26-1039856212458979">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Loo</surname><given-names>CK</given-names></name>
<name><surname>Sainsbury</surname><given-names>K</given-names></name>
<name><surname>Sheehan</surname><given-names>P</given-names></name>
<etal/></person-group>. <article-title>A comparison of RUL ultrabrief pulse (0.3 ms) ECT and standard RUL ECT</article-title>. <source>Int J Neuropsychopharmacol</source> <year>2008</year>; <volume>11</volume>: <fpage>883</fpage>–<lpage>890</lpage>.</citation>
</ref>
<ref id="bibr27-1039856212458979">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sackheim</surname><given-names>H</given-names></name>
<etal/></person-group>. <article-title>Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy</article-title>. <source>Brain Stimul</source> <year>2008</year>; <volume>1</volume>: <fpage>71</fpage>–<lpage>83</lpage>.</citation>
</ref>
<ref id="bibr28-1039856212458979">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sienaert</surname><given-names>P</given-names></name>
<name><surname>Vansteelandt</surname><given-names>K</given-names></name>
<name><surname>Demyttenaere</surname><given-names>K</given-names></name>
<etal/></person-group>. <article-title>Randomised comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: clinical efficacy</article-title>. <source>J Affect Disord</source> <year>2009</year>; <volume>116</volume>: <fpage>106</fpage>–<lpage>112</lpage>.</citation>
</ref></ref-list>
</back>
</article>